Skip to Main Content
PFF Help Center
(844) 825-5733
Facebook
LinkedIn
YouTube
Instagram
Join the PFF Registry
Donate
Shop PFF
Menu
Understanding PF
Newly Diagnosed: Start Here
PF Basics: Info for Newly Diagnosed Patients
About Pulmonary Fibrosis
What is Pulmonary Fibrosis?
Causes
Diagnosis
Symptoms
Glossary and Abbreviations
Types of Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis
Environmental
Occupational
Drug-Induced
Radiation-Induced
Autoimmune Connective Tissue Disease
Other Types of Pulmonary Fibrosis
Treatment Options
Supplemental Oxygen
Pulmonary Rehabilitation
Pulmonary Rehabilitation Toolkit
Symptom Management
Medication
Lung Transplantation
Patients & Caregivers
Medical and Support Resources
Find Medical Care
Find a Support Group
PFF Help Center
Pulmonary Rehabilitation Toolkit
For the Caregiver
Stories from the Heart
Clinical Trials
Medical Statements
Education Resources
Fact Sheets
Maintain Your Health
Videos
Webinars
Telemedicine
Educational Materials
Recursos de fibrosis pulmonar
PFF Insights Blog
Clinical Trials Blog
PFF Summit
Oxygen Therapy
What is Oxygen Therapy?
Benefits
Oxygen Rights and Resources
Oxygen Therapy FAQs
Join a Research Study
PFF Community Registry
APPLe Familial Pulmonary Fibrosis Study
PRECISIONS
Find a clinical trial
Researchers & Healthcare Providers
Clinical Resources
PFF Clinical Resource Hub
Webinars
CME/CE Library
Position Statements
Educational Materials
PFF Summit
Fact Sheets
Research Opportunities
PFF Community Registry
PFF Scholars and Other Research Opportunities
Familial Pulmonary Fibrosis Research Award
PROLIFIC
Community Engagement
Care Center Network
Nurse and Allied Health Network
Host an Event
Book a PFF Ambassador
Request Sponsorship Support
Ways to Give
Ways to Give
Workplace & Matching Giving
Planned Giving
Donor Advised Funds
Donate Stocks & Bonds
Qualified Charitable Distribution (QCD)
Donate Cryptocurrency
Donation FAQs
2026 Tax Law Changes
Albert Rose Legacy Society
Shop PFF
Honor and Memorial Giving
Make a Gift in Honor or Memory
Find a Tribute
Create a Tribute
Fundraising Events
PFF Walk
Broadway Belts for PFF!
Team PFF
Community Walk
Corporate Giving
Corporate Partners
PFF Corporate Committee
Donate Today
Mail-in Donations
Donate Monthly
Get Involved
Events
Attend an Event
Fundraise with Team PFF
Fundraising on Facebook
PFF Walk
PFF Summit 2025
Broadway Belts for PFF!
ILD Day
PFF Education Symposium
Let's Talk Cough
Volunteer
Join the PFF Community Registry
Start a Support Group
Be a PFF Advocate
Share Your Story
Become a PFF Ambassador
PF Awareness Month
Join a Board Committee
Shop PFF
PFF Walk
About the PFF Walk
Bay Area
Chicago
Dallas
National Walk Day
NYC Metro
Pittsburgh
Tampa
Washington, D.C.
Join the PFF Registry
What is the PFF Registry
Getting started
Submit a research proposal
History of the PFF Registry
Registry Report
Meet The Team
Sponsors
FAQ
About Us
Who We Are
Leadership
Mission & History
Medical Advisory Committees
Financials
Our 25 year anniversary
What We Do
The PFF is Me Strategic Plan
Patient Support Programs
Policy & Advocacy
PFF Funded Research
Education
News and Media
News
PFF In The Media
Breathe Bulletin
Media Resources
Careers
Contact Us
Search
Search
External News
Home
External News
Indalo Therapeutics Initiates Dosing in IPF Patients with Lead Antifibrotic Drug Candidate IDL-2965
March 09, 2021
Promedior Enters Into Definitive Merger Agreement To Be Acquired By Roche
March 09, 2021
Bellerophon Presents New Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at Pulmonary Fibrosis Foundation Summit 2019
March 09, 2021
Analysis of fibroblast migration dynamics in idiopathic pulmonary fibrosis using image-based scaffolds of the lung extracellular matrix
March 09, 2021
Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis
March 09, 2021
Bellerophon Announces Positive Initial Data from Acute Hemodynamic Dose Escalation Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
March 09, 2021
Biomarkers of Extracellular Matrix Turnover in Patients With Idiopathic Pulmonary Fibrosis Given Nintedanib
March 09, 2021
Blade Therapeutics Expands Anti-Fibrotic Pipeline With Acquisition of ATXCo and Its Autotaxin Inhibitor (PAT-409)
March 09, 2021
Galecto raises €79 million ($90 million) to run late-phase IPF trial
March 09, 2021
Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis
March 09, 2021
L-CsA-i demonstrates therapeutic potential for Bonchiolitis Obliterans Syndrome (BOS)
March 09, 2021
Mortality for sarcoidosis patients on the transplant wait list in the Lung Allocation Score era: Experience from a high volume center
March 09, 2021
miRagen Presents Preclinical Data in Pulmonary Fibrosis Using Second Generation microRNA-29 Replacement Product Candidate at the 2019 American Thoracic Society International Conference
March 09, 2021
Promising steps towards a treatment for pulmonary fibrosis
March 09, 2021
US FDA grants saracatinib Orphan Drug Designation for idiopathic pulmonary fibrosis
March 09, 2021
Veracyte announces data published in the Lancet Respiratory Medicine demonstrate that the Envisia Genomic Classifier improves diagnosis of IPF
March 09, 2021
Veracyte Announces New Data Demonstrating ENVISIA Genomic Classifer Improves IPF Diagnosis
March 09, 2021
Viral Infection Increases the Risk of Idiopathic Pulmonary Fibrosis: A Meta-analysis
March 09, 2021
Yale study provides insights into how fibrosis progresses in the human lung
March 09, 2021
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
March 09, 2021
1
2
3
4
5
6
7
8
9
